Skip to main content
Advertisement
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
ADVERTISEMENT
Marina Komaroff, DrPH
Efficacy and Safety of an Asenapine Transdermal System (HP-3070) for Treatment of Adults with Schizophrenia: A Phase 3 Randomized, Placebo-Controlled, Inpatient Study
Background: HP-3070, an asenapine transdermal patch for schizophrenia, offers favorable pharmacokinetics with minimal peak and trough fluctuations.
David Walling , PhD, CNS, MD;
Courtney Zeni , PhD;
Marina Komaroff , DrPH;
Leslie Citrome , MD;
Alexandra Park , BSc;
11/22/2019
Featured Webinar
Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications
Advertisement
Advertisement
Advertisement
Advertisement
Upcoming Events
November 23 – November 24
December 4 – December 5
December 6 – December 7
December 9 – December 11
December 9 – December 11
December 12 – December 13
December 14 – December 15
February 2 – February 5
February 27 – March 1
March 17 – March 19
See Full Calendar
Advertisement
Advertisement
Advertisement